Home > Publications database > The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanoma > print

001     296077
005     20250103121048.0
024 7 _ |a 10.1080/2162402X.2024.2430066
|2 doi
024 7 _ |a 2162-4011
|2 ISSN
024 7 _ |a 2162-402X
|2 ISSN
037 _ _ |a DKFZ-2025-00025
082 _ _ |a 610
100 1 _ |a Wiecken, Melanie
|b 0
245 _ _ |a The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanoma
260 _ _ |a Abingdon
|c 2025
|b Taylor & Franics
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1735819364_24214
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Machiraju, Devayani
|b 1
700 1 _ |a Chakraborty, Shounak
|b 2
700 1 _ |a Mayr, Eva-Maria
|b 3
700 1 _ |a Lenoir, Bénédicte
|0 P:(DE-He78)4671d97058e8d2ddb314e6be4de0c403
|b 4
|u dkfz
700 1 _ |a Eurich, Rosa
|0 P:(DE-He78)5a1d2e85593bd6df001fb4a1320b77db
|b 5
|u dkfz
700 1 _ |a Richter, Jasmin
|b 6
700 1 _ |a Pfarr, Nicole
|0 0000-0002-5977-5375
|b 7
700 1 _ |a Halama, Niels
|0 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601
|b 8
|u dkfz
700 1 _ |a Hassel, Jessica C.
|b 9
773 _ _ |a 10.1080/2162402X.2024.2430066
|g Vol. 14, no. 1, p. 2430066
|0 PERI:(DE-600)2645309-5
|n 1
|p 2430066
|t OncoImmunology
|v 14
|y 2025
|x 2162-4011
909 C O |o oai:inrepo02.dkfz.de:296077
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)4671d97058e8d2ddb314e6be4de0c403
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)5a1d2e85593bd6df001fb4a1320b77db
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ONCOIMMUNOLOGY : 2022
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-11-18T12:16:37Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-11-18T12:16:37Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2022-11-18T12:16:37Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-19
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-19
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-19
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ONCOIMMUNOLOGY : 2022
|d 2023-08-19
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-19
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-19
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 0
920 1 _ |0 I:(DE-He78)D196-20160331
|k D196
|l Translationale Immuntherapie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a I:(DE-He78)D196-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21